LIGHT Enhanced Bispecific Antibody Armed T Cells to Treat Immunotherapy Resistant Colon Cancer

By
Justin.choi
-
0
38
Scientists demonstrate that activated T cells armed with anti-CD3 x anti-EGFR bispecific antibody increases tumor infiltrating lymphocytes and mediate anti-tumor cytotoxicity while decreasing tumor cell viability.
[Oncogene]

Sorry, but the selected Zotpress account can't be found.

Full Article